Trials in Boston, Massachusetts
Here are the top 10 medical studies for breast cancer in Boston, Massachusetts
Popular Filters
Phase 3 Trials
Chemotherapy
Chemotherapy + HER2-Targeted Therapy With or Without Hormone Therapy for Breast Cancer
Recruiting4 awardsPhase 3
Hot Springs, Arkansas
This trial is studying a combination of drugs given with or without hormone therapy to see how well they work in treating patients with hormone receptor-positive, HER2-positive breast cancer.
Hormone Therapy
Fulvestrant + Anastrozole for Breast Cancer
Recruiting4 awardsPhase 3
Birmingham, Alabama
This trial is testing whether neoadjuvant endocrine therapy with fulvestrant or the combination of anastrozole and fulvestrant is better than anastrozole when given before surgery to shrink the cancer and stop it from growing.
CDK4/6 Inhibitor
CDK4/6 Inhibitors for Metastatic Breast Cancer
Recruiting2 awardsPhase 3
Boston, Massachusetts
"This trial aims to find a better dosing strategy for CDK4/6 inhibitors in older patients with Metastatic Breast Cancer to help them tolerate side effects and stay on treatment longer. The study
Trials With No Placebo
Monoclonal Antibodies
SGN-B6A for Cancer
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing a new drug called sigvotatug vedotin alone and with other treatments to see if it is safe and effective for people with solid tumors. It will also check for any side effects. The study includes different parts to determine the best dose and to see how well the drug works alone and in combination with other treatments.
Chemotherapy Reduction After Surgery for Breast Cancer
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial is studying how well paclitaxel, trastuzumab, and pertuzumab work in eliminating chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery.
Endocrine Therapy Interruption for Breast Cancer During Pregnancy
Recruiting1 award15 criteria
Boston, Massachusetts
This trial is investigating whether or not temporarily interrupting endocrine therapy, in order to allow pregnancy, increases the risk of breast cancer recurrence. The study will also evaluate different indicators related to fertility, pregnancy, and breast cancer biology.
Chemotherapy
Chemotherapy + HER2-Targeted Therapy With or Without Hormone Therapy for Breast Cancer
Recruiting4 awardsPhase 3
Hot Springs, Arkansas
This trial is studying a combination of drugs given with or without hormone therapy to see how well they work in treating patients with hormone receptor-positive, HER2-positive breast cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.